This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: 3M Innovative Properties Company. Active years: 2007-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2011
Title: Isidro Angelo E Zarraga: Innovator in Immune Response Modifiers
Introduction
Isidro Angelo E Zarraga is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of immunology, particularly in the development of immune response modifiers. With a total of 3 patents to his name, Zarraga's work has the potential to impact therapeutic approaches in immune response modulation.
Latest Patents
Zarraga's latest patents include innovative inventions that focus on enhancing immune responses. One of his notable patents is titled "Delivery of immune response modifier compounds." This invention provides immune response modifiers (IRMs) that are associated with macromolecular support materials. The IRM compounds in these complexes retain their biological activity, allowing for localized biological effects. Another significant patent is "Immunostimulatory compositions and methods of stimulating an immune response." This invention presents immunostimulatory compositions that combine an immune response modifier portion with an antigenic portion, further advancing the field of immunotherapy.
Career Highlights
Zarraga is currently associated with 3M Innovative Properties Company, where he continues to innovate and develop new technologies. His work at 3M has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of Zarraga's notable coworkers include Paul D Wightman and Ross M Kedl. Their collaborative efforts have likely enhanced the research and development of immune response modifiers.
Conclusion
Isidro Angelo E Zarraga is a prominent inventor whose work in immune response modifiers is paving the way for advancements in immunotherapy. His contributions are significant in the ongoing quest to improve immune response treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
